Mgr. Tomáš Loja, Ph.D.
Technical specialist, Genomics Core Facility
office: bldg. E35/234
Kamenice 753/5
625 00 Brno
phone: | +420 549 49 7455 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 109
2023
-
Genome-wide CRISPR/Cas9 knockout screening revealed genes involved in CD20 regulation.
Year: 2023, type: Conference abstract
-
Characterisation of Macrophage Response to Nickel Nanoparticles and Ions Released from Biomaterials
Year: 2023, type: Conference abstract
-
Identification of novel targets that upregulate CD20 expression in rituximab-resistant cells with the use of genomewide CRISPR screening.
Year: 2023, type: Conference abstract
-
Inhibition of acute myeloid leukemia using palbociclib and ponatinib in a patient-derived xenograft model.
Year: 2023, type: Conference abstract
-
The role of casein kinase 1 inhibition in treatment of chronic lymphocytic leukemia.
Year: 2023, type: Conference abstract
2022
-
GAB1 as novel therapeutic target in B lymphoid and myeloid malignancies
Year: 2022, type: Conference abstract
-
Sekvenování dlouhých nekódujících RNA v exozomech u pacientů s kolorektálním karcinomem
Klinická onkologie, year: 2022, volume: 35, edition: Supplementum 1, DOI
-
Versatile coculture systém to study chronic lymhocytic leukemia proliferation.
Year: 2022, type: Conference abstract
2021
-
Acute myeloid leukemia regression induced by palbociclib and ponatinib in patient –derived xenograft model.
Year: 2021, type: Conference abstract
-
Detekce transpozibilních elementů u hematologických malignit.
Year: 2021, type: Conference abstract